| Description | This product is a HA stalk-binding antibody. F11, which did not exhibit NT activity in the IgG state, did show NT activity when converted to IgA, clearly suggesting that anti-viral potency is derived from the IgA backbone. |
| Clonality | Monoclonal |
| Host Species | Human |
| Target Species | Influenzavirus A (IAV) |
| Cross Reactivity | H1N1, H3N2 |
| EC50 | 138 ng/mL (A/New Caledonia/20/1999 (H1N1, NC20)) |
| Isotype | Human IgA |
| Expression Species | HEK293F or CHO |
| Conjugation | None |
| Purity | >95%, determined by SDS-PAGE and SEC-HPLC |
| Endotoxin | <1 EU/mg |
| Purification | Protein A purified |
| Sterility | 0.2 μM filtered |
| Formulation | PBS, pH 7.4 |
| Preservation | No preservatives |
| Stabilizer | No stabilizers |
| Storage | Store at 4°C within a week. For longer storage, aliquot and store at -20°C. |
| Application | ELISA; Neut |
| Application Notes | ELISA: 250 ng |
| ELISA | Enzyme-Linked Immunosorbent Assay Protocol |
| WB | Western Blot Protocol |
| FC | Flow Cytometry Protocol |
| Target | IAV HA stalk |
| Alternative Name | Influenza A virus Hemagglutinin; Influenza A virus; Hemagglutinin; HA; IAV; stalk |
| Research Area | Microbiology |
